Page last updated: 2024-11-05

urapidil and Shock

urapidil has been researched along with Shock in 1 studies

Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.

Research Excerpts

ExcerptRelevanceReference
"Urapidil was used for α1A-adrenergic receptor blockade in dosages, which did not modify the MABP-response to blood loss."1.46Redistribution of Cerebral Blood Flow during Severe Hypovolemia and Reperfusion in a Sheep Model: Critical Role of α1-Adrenergic Signaling. ( Bischoff, SJ; Huber, O; Lehmann, T; Matziolis, G; Rakers, F; Reiche, J; Rupprecht, S; Schiffner, R; Schmidt, M; Schubert, H; Schwab, M, 2017)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schiffner, R1
Bischoff, SJ1
Lehmann, T1
Rakers, F1
Rupprecht, S1
Reiche, J1
Matziolis, G1
Schubert, H1
Schwab, M1
Huber, O1
Schmidt, M1

Other Studies

1 other study available for urapidil and Shock

ArticleYear
Redistribution of Cerebral Blood Flow during Severe Hypovolemia and Reperfusion in a Sheep Model: Critical Role of α1-Adrenergic Signaling.
    International journal of molecular sciences, 2017, May-11, Volume: 18, Issue:5

    Topics: Adrenergic alpha-1 Receptor Agonists; Analysis of Variance; Animals; Arterial Pressure; Arterioles;

2017